In our studies using Ras/Raf mutant cancer cells, co-treatment with the ferroptosis inhibitor Ferrostatin-1 rescued EC359-induced cell death, and Western blot analysis confirmed downregulation of the ferroptosis regulator GPX4. This evidence concerns the gene GPX4 and cancer.